CHIP News and Research

RSS

Researchers use CAD to load dozens of tests on lab-on-a-chip

When you get sick, your physician may take a sample of your blood, send it to the lab and wait for results. In the near future, however, doctors may be able to run those tests almost instantly on a piece of plastic about the size of credit card.

9 May 2014

The Leukemia & Lymphoma Society passes $1 billion mark in blood cancer research investment

The Leukemia & Lymphoma Society announced that it has passed the $1 billion mark in research investment, a significant milestone in the cancer research landscape as LLS continues its 65 year pursuit of advancing breakthrough therapies, finding cures and ensuring access to life-saving therapies for all blood cancer patients.

8 May 2014

First Edition: May 8, 2014

Today's headlines include reports from a Capitol Hill hearing featuring health insurers' testimony about their experiences with new enrollment under the health law.

8 May 2014

MAXIMUS revenue increases 35% to $439.0 million in second quarter fiscal 2014

MAXIMUS, a leading provider of government services worldwide, today reported financial results for the three and six months ended March 31, 2014.

8 May 2014

Scientists develop bone marrow-on-a-chip to test effects of new drugs, toxic agents on bone marrow

The latest organ-on-a-chip from Harvard's Wyss Institute for Biologically Inspired Engineering reproduces the structure, functions and cellular make-up of bone marrow, a complex tissue that until now could only be studied intact in living animals, Institute researchers report in the May 4, 2014, online issue of Nature Methods.

6 May 2014

Enrichment of highly abundant epigenetic marks from endometrial stromal cells

Chromatrap®, the novel solid-based matrix for chromatin immunoprecipitation (ChIP) assays, available from Porvair Sciences, has been successfully used to isolate high quality chromatin from difficult biopsy material.

From Chromatrap® - Porvair Sciences Ltd 30 Apr 2014

OSI Systems reports revenues of $204 million for third quarter fiscal 2014

OSI Systems, Inc. today announced financial results for the third fiscal quarter ended March 31, 2014, including, among other things, the introduction of reporting Adjusted EBITDA, a discussion of which can be found below, under the caption, "New Presentation of Non-GAAP Financial Measure."

30 Apr 2014

Scientists develop new circuit board modeled on human brain

The Neurogrid circuit board can simulate orders of magnitude more neurons and synapses than other brain mimics on the power it takes to run a tablet computer.

29 Apr 2014

HHS calls health care providers to expand use of medications to treat opioid addiction, reduce overdose deaths

A national response to the epidemic of prescription opioid overdose deaths was outlined yesterday in the New England Journal of Medicine by leaders of agencies in the U.S. Department of Health and Human Services.

26 Apr 2014

Lawsuit challenging health law subsidies gains backing of 38 GOP lawmakers

The challenge, brought by Sen. Ron Johnson, R-Wis., targets the rule allowing the federal government to pay part of the health insurance premiums for lawmakers and some staffers.

25 Apr 2014

First Edition: April 23, 2014

Today's headlines include a range of health policy news reports, including developments related to the health law, to the marketplace and at the state level.

23 Apr 2014

Viewpoints: The case against Jenny Mccarthy's vaccine stand; apathy on HIV; defeating Alzheimer's

What do you call someone who sows misinformation, stokes fear, abets behavior that endangers people's health, extracts enormous visibility from doing so and then says the equivalent of "Who? Me?" I'm not aware of any common noun for a bad actor of this sort. But there's a proper noun: Jenny McCarthy (Frank Bruni, 4/21).

23 Apr 2014

New FDA-approved device reduces seizures in patients with medication-resistant epilepsy

A recently FDA-approved device has been shown to reduce seizures in patients with medication-resistant epilepsy by as much as 50 percent. When coupled with an innovative electrode placement planning system developed by physicians at Rush, the device facilitated the complete elimination of seizures in nearly half of the implanted Rush patients enrolled in the decade-long clinical trials.

23 Apr 2014

FDA approves Cyramza to treat patients with advanced stomach cancer

Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the U.S. Food and Drug Administration (FDA) approved a molecularly targeted drug as second-line treatment in advanced stomach cancer that has progressed after standard chemotherapy has failed.

22 Apr 2014

FDA approves molecularly targeted drug as second-line treatment for advanced stomach cancer

Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the U.S. Food and Drug Administration approved a molecularly targeted drug as second-line treatment in advanced stomach cancer that has progressed after standard chemotherapy has failed.

22 Apr 2014

Viewpoints: Obamacare dilemma -- some people dislike the law but embrace its provisions; are health costs falling?

Polls have consistently shown that even though the public opposes Obamacare, people like some of its most significant provisions. That's particularly true of the requirement that insurers ignore preexisting conditions when signing up customers for coverage.

16 Apr 2014

CBO shrinks estimate of health law spending based on lower subsidy costs

Expanding health coverage under the health law will also slow premium growth, helping lower the total cost of the law, the nonpartisan office said.

16 Apr 2014

Engineers develop tools to efficiently analyze living cells

For more than a decade Chang Lu, associate professor of chemical engineering at Virginia Tech, has worked on the development of tools to efficiently analyze living cells. The long-term goal is to gain a better understanding of a range of diseases.

15 Apr 2014

Bio-Rad Laboratories buys GnuBIO

GnuBIO, a privately-held life sciences company that has developed a droplet-based DNA sequencing technology, today announced that it was acquired by Bio-Rad Laboratories, Inc. With this acquisition, Bio-Rad will expand its Digital Biology Center and establish a research and development site in Cambridge, Massachusetts.

11 Apr 2014

Medicaid enrollment increases by 3 million since health law enrollment began

The number is not yet complete because some states have not reported their numbers and it doesn't include March sign-ups.

8 Apr 2014

CHIP News and Research

Researchers use CAD to load dozens of tests on lab-on-a-chip

The Leukemia & Lymphoma Society passes $1 billion mark in blood cancer research investment

First Edition: May 8, 2014

MAXIMUS revenue increases 35% to $439.0 million in second quarter fiscal 2014

Scientists develop bone marrow-on-a-chip to test effects of new drugs, toxic agents on bone marrow

Enrichment of highly abundant epigenetic marks from endometrial stromal cells

OSI Systems reports revenues of $204 million for third quarter fiscal 2014

Scientists develop new circuit board modeled on human brain

HHS calls health care providers to expand use of medications to treat opioid addiction, reduce overdose deaths

Lawsuit challenging health law subsidies gains backing of 38 GOP lawmakers

First Edition: April 23, 2014

Viewpoints: The case against Jenny Mccarthy's vaccine stand; apathy on HIV; defeating Alzheimer's

New FDA-approved device reduces seizures in patients with medication-resistant epilepsy

FDA approves Cyramza to treat patients with advanced stomach cancer

FDA approves molecularly targeted drug as second-line treatment for advanced stomach cancer

Viewpoints: Obamacare dilemma -- some people dislike the law but embrace its provisions; are health costs falling?

CBO shrinks estimate of health law spending based on lower subsidy costs

Engineers develop tools to efficiently analyze living cells

Bio-Rad Laboratories buys GnuBIO

Medicaid enrollment increases by 3 million since health law enrollment began

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News